CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy

被引:1
|
作者
Hoshimoto, K [1 ]
Hayashi, M [1 ]
Ohkura, T [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Obstet & Gynecol, Koshigaya Hosp, Koshigaya, Saitama 343, Japan
关键词
CD26; expression; CD30; lymphocyte; pregnancy; cytokine balance;
D O I
10.1159/000052932
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
It is increasingly apparent that the Th1/Th2 cell ratio is decreased during pregnancy. In a previous study, we revealed that combined analysis of soluble CD26 and CD30 might be a potent surrogate tool for evaluating the Th1/Th2 balance during pregnancy. Therefore, in the present study, we elucidated whether the CD26 and CD30 expression on the surface of lymphocyte is useful marker for Th1 and Th2 lymphocytes, respectively, during pregnancy with flow cytometric technique. The peripheral blood samples were obtained from 6 non-pregnant healthy women, 8 healthy pregnant women in the first trimester and 12 pregnant women in the third trimester. The mean percentages of CD26 expression did not differ significantly among these groups (p = 0.45). Also, the mean percentages of CD30 expression did not differ significantly among these groups (p = 0.32). From the present study, the expression of CD26 and CD30 did not appear to be a useful marker for Th1 and Th2 lymphocytes during pregnancy. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 50 条
  • [41] Cytokeratin and CD30 expression in dysgerminoma
    Cossu-Rocca, Paolo
    Jones, Timothy D.
    Roth, Lawrence M.
    Eble, John N.
    Zheng, Wenxin
    Karim, Fadi W. Abdul
    Cheng, Liang
    HUMAN PATHOLOGY, 2006, 37 (08) : 1015 - 1021
  • [42] CD30 expression in follicular lymphoma
    Gardner, LJ
    Polski, JM
    Evans, L
    Perkins, SL
    Dunphy, CH
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2001, 125 (08) : 1036 - 1041
  • [43] CD30 expression in melanocytic lesions
    Battocchio, S
    Stas, M
    Maes, A
    van den Oord, JJ
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 1999, 7 (02): : 169 - 172
  • [44] CD30 expression in nonlymphomatous malignancies
    Sharman, Jeff Porter
    Goldschmidt, Jerome H.
    Burke, John M.
    Hellerstedt, Beth A.
    McIntyre, Kristi
    Yasenchak, Christopher A.
    Boyd, Thomas E.
    Ruxer, Robert L.
    Patel-Donnelly, Dipti
    Braiteh, Fadi S.
    Forero-Torres, Andres
    Savin, Michael A.
    Albertson, Tina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] CD26 EXPRESSION ON SYNOVIAL-CELLS
    HASUNUMA, T
    MORIMOTO, C
    NISHIOKA, K
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S159 - S159
  • [46] Localization of CD26 to the surface of platelets.
    Gong, K
    Liu, P
    Costalonga, M
    Kraus, DW
    Herzberg, MC
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 286 - 286
  • [47] Altered expression of the lymphocyte activation antigen CD30 in active celiac disease
    Periolo, N.
    Guillen, L.
    Bernardo, D.
    Niveloni, S. I.
    Hwang, H. J.
    Garrote, J. A.
    Bai, J. C.
    Arranz, E.
    Chernavsky, A. C.
    AUTOIMMUNITY, 2010, 43 (04) : 288 - 298
  • [48] CD30 ligand in lymphoma patients with CD30(+) tumors
    Younes, A
    Consoli, U
    Snell, V
    Clodi, K
    Kliche, KO
    Palmer, JL
    Gruss, HJ
    Armitage, R
    Thomas, EK
    Cabanillas, F
    Andreeff, M
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (11) : 3355 - 3362
  • [49] CD26 and Cancer
    Cordero, Oscar J.
    CANCERS, 2022, 14 (21)
  • [50] Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions
    Makhseed, M
    Raghupathy, R
    Azizieh, F
    Farhat, R
    Hassan, N
    Bandar, A
    HUMAN REPRODUCTION, 2000, 15 (09) : 2011 - 2017